Dabigatran etexilate (Pradaxa®) for preventing warfarin-induced skin necrosis in a patient with severe protein C deficiency.

Authors :: Hermans C
Eeckhoudt S
Lambert C
Source :: Thrombosis and haemostasis [Thromb Haemost] 2012 Jun; Vol. 107 (6), pp. 1189-91. Date of Electronic Publication: 2012 Mar 08.
Publication Year :: 2012

Subjects :: Dabigatran
Drug Eruptions etiology
Drug Eruptions pathology
Drug Substitution
Female
Humans
Necrosis
Protein C Deficiency blood
Protein C Deficiency genetics
Severity of Illness Index
Skin pathology
Young Adult
Anticoagulants adverse effects
Benzimidazoles therapeutic use
Drug Eruptions prevention & control
Protein C Deficiency drug therapy
Pyridines therapeutic use
Skin drug effects
Warfarin adverse effects

Full Text Access

Tools